SSG’s Pharma Bio-Logistics service suite offers consultative and unconventional solutions that create holistic value. We convert traditional decentralized supply models into innovative and agile, demand-centric distribution models resulting in consistent financial benefits throughout the supply chain.
The highly fragmented and emerging market of Asia presents Principals with multiple challenges. SSG addresses challenges by engaging these fragmented markets through centralized regulatory support, inventory planning and logistics execution.
SSG increases Principals’ market responsiveness by consolidating in-country demand forecasts and integrating it at its demand driven RDC. Appropriate stock levels are placed in the RDC, closer to the small and fragmented end markets, allowing Principals to achieve unprecedented economies of scale in purchasing and manufacturing. Principals will be able to meet regional demands despite inventory reductions through consolidation, without compromising the fulfillment ability. A major enabler of increased responsiveness to end markets is SSG’s ability to provide late stage product customization (secondary redressing) through the RDC’s repackaging services. This postponement strategy leads to significant MOQ reduction, thus reducing obsolescence risks.
SSG’s network of countries provides real-time market feedback. SSG provides a compelling solution for shorter lead times to markets for "made to order" products as compared to direct shipments of "made to stock" products to markets from manufacturers.
In the current business environment, the ability to outsource and achieve holistic cost reductions by rationalizing supply chains is a key success factor for market leaders. Can you afford not to change?
Click here for more information.